Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2004-06-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial
NCT01615705
Full-Leg vs Below-Knee Elastic Stockings for Prevention of the Post-Thrombotic Syndrome
NCT00426075
A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg
NCT06965998
Rivaroxaban Anticoagulation for Superficial Vein Thrombosis
NCT02123524
Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)
NCT03465735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
36-mth follow up visit
The cohort will consist of original subjects of the SOX Trial who consent to participate in the extension to follow up sub study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Who have no contraindications to standard treatment with heparin and/or warfarin, and
* Who provide informed consent to participate
Exclusion Criteria
* Limited lifespan (estimated \< 6 months)
* Geographic inaccessibility preventing return for follow-up visits
* Inability to apply stockings daily and unavailability of a caregiver to apply stockings daily
* Treatment of acute DVT with thrombolytic agents
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Heart and Stroke Foundation of Canada
OTHER
Sigvaris Corporation
INDUSTRY
Sir Mortimer B. Davis - Jewish General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Susan Kahn
SOX Trial Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan R. Kahn, M.D., M.Sc.
Role: PRINCIPAL_INVESTIGATOR
Sir Mortimer B. Davis - Jewish General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Victoria Heart Institute Foundation
Victoria, British Columbia, Canada
St. Boniface General Hospital
Winnipeg, Manitoba, Canada
QE II Health Sciences Centre
Halifax, Nova Scotia, Canada
Hamilton Health Sciences - General Hospital
Hamilton, Ontario, Canada
Hamilton Health Sciences - Chedoke Division
Hamilton, Ontario, Canada
Hamilton Health Sciences - McMaster University Medical Centre
Hamilton, Ontario, Canada
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
Hamilton Health Sciences - Henderson General Hospital
Hamilton, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
The Ottawa Hospital, Civic Campus
Ottawa, Ontario, Canada
Sunnybrook & Women's College Health Sciences Centre
Toronto, Ontario, Canada
University Health Network
Toronto, Ontario, Canada
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Centre Hospitalier de l'Université de Montréal - Hôpital Notre-Dame
Montreal, Quebec, Canada
Royal Victoria Hospital - McGill University Health Centre
Montreal, Quebec, Canada
Montreal General Hospital - McGill University Health Centre
Montreal, Quebec, Canada
Sir Mortimer B. Davis - Jewish General Hospital
Montreal, Quebec, Canada
St. Mary's Hospital Centre
Montreal, Quebec, Canada
Hôpital du Sacré-Coeur de Montréal
Montreal, Quebec, Canada
Centre hospitalier affilié universitaire de Québec, Hôpital de l'Enfant-Jésus
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kahn SR, Shbaklo H, Shapiro S, Wells PS, Kovacs MJ, Rodger MA, Anderson DR, Ginsberg JS, Johri M, Tagalakis V; SOX Trial Investigators. Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial. BMC Cardiovasc Disord. 2007 Jul 24;7:21. doi: 10.1186/1471-2261-7-21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISRCTN71334751; NCT00143598
Identifier Type: REGISTRY
Identifier Source: secondary_id
MOP-102610
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.